Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 181 AL 195

Regional cerebral blood flow and aberrant motor behaviour in Alzheimer's disease

Reilly TJ, Staff RT, Ahearn TS, Bentham P, Wischik CM, Murray AD.

Behav Brain Res. 2011 Sep 23;222(2):375-9. doi: 10.1016/j.bbr.2011.04.003. Epub 2011 Apr 12.

Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology

Obulesu M, Venu R, Somashekhar R.

Neurochem Res. 2011 Aug;36(8):1329-35. doi: 10.1007/s11064-011-0475-5. Epub 2011 Apr 21.

γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes

Imbimbo BP, Giardina GA.

Curr Top Med Chem. 2011;11(12):1555-70. doi: 10.2174/156802611795860942.

γ-secretase substrates and their implications for drug development in Alzheimer's disease

Lleó A, Saura CA.

Curr Top Med Chem. 2011;11(12):1513-27. doi: 10.2174/156802611795861004.

Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future

Freitas C, Mondragón-Llorca H, Pascual-Leone A.

Exp Gerontol. 2011 Aug;46(8):611-27. doi: 10.1016/j.exger.2011.04.001. Epub 2011 Apr 14.

Mutations that replace aromatic side chains promote aggregation of the Alzheimer's Aβ peptide

Armstrong AH, Chen J, McKoy AF, Hecht MH.

Biochemistry. 2011 May 17;50(19):4058-67. doi: 10.1021/bi200268w. Epub 2011 Apr 22.

γ-Secretase-regulated mechanisms similar to notch signaling may play a role in signaling events, including APP signaling, which leads to Alzheimer's disease

Nakayama K, Nagase H, Koh CS, Ohkawara T.

Cell Mol Neurobiol. 2011 Aug;31(6):887-900. doi: 10.1007/s10571-011-9688-z. Epub 2011 Apr 23.

Alzheimer's pathogenesis: is there neuron-to-neuron propagation?

Braak H, Del Tredici K.

Acta Neuropathol. 2011 May;121(5):589-95. doi: 10.1007/s00401-011-0825-z. Epub 2011 Apr 24.

More good news about the magic ion: lithium may prevent dementia

Young AH.

Br J Psychiatry. 2011 May;198(5):336-7. doi: 10.1192/bjp.bp.110.082875.

Drug discovery for neurodegenerative diseases: challenges and novel biochemical targets dedicated to the memory of Mark A. Smith for his inspiring contribution to Alzheimer's disease

Britton GB, Smith MA, Perry G, Sambamurti K, Jagannatha Rao KS.

J Alzheimers Dis. 2011;24 Suppl 2:1-2. doi: 10.3233/JAD-2011-110021.

[Do medicines with aim to anti-Alzheimer favor the arisen of epileptic crisis? Discussion about 3 clinical cases]

Roy M, Castro-Lionard K, Crawford-Achour E, Desseigne N, Beyens MN, Guy C, Imler D, Cornillon D.

Therapie. 2011 May-Jun;66(3):291-3. doi: 10.2515/therapie/2011038.

Effects of distraction and pictorial illustration on memory for countries in older adults with probable Alzheimer's disease

Boudreaux EO, Cherry KE, Elliott EM, Hicks JL.

Exp Aging Res. 2011 May;37(3):293-309. doi: 10.1080/0361073X.2011.568816.

Medical foods for Alzheimer's disease

Shah RC.

Drugs Aging. 2011 Jun 1;28(6):421-8. doi: 10.2165/11587380-000000000-00000.

Aβ oligomer-induced synapse degeneration in Alzheimer's disease

Wilcox KC, Lacor PN, Pitt J, Klein WL.

Cell Mol Neurobiol. 2011 Aug;31(6):939-48. doi: 10.1007/s10571-011-9691-4. Epub 2011 May 3.

Management of suspected Alzheimer's disease patients by specialist physicians at the first visit in Spain: First Consultation Study

Martínez Lozano MD, Guzmán Quilo C; Primeras Consultas Study Group.

Expert Rev Neurother. 2011 May;11(5):657-63. doi: 10.1586/ern.11.45.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias